drugset / Trial / NCT05789732

Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones

NCT05789732

Completed 168 enrolled Benha University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will compare the efficacy of silodosin, tadalafil versus silodosin plus tadalafil as Medical Expulsive Therapy (MET) for lower ureteric stones.

Timeline

Start
2022-03-30
Primary completion
2022-08-30
Completion
2022-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Silodosin Unknown 8 mg
Subject Tadalafil Small molecule 5 mg

Indications